Oragenics (OGEN) FCF Margin Growth (1y) (2011 - 2023)
Oragenics (OGEN) FCF Margin Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 811.00 |
| 10 | Oragenics | 2.35 Mn | 2.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -1.57 Mn |
| Jun 30, 2023 | -844,383.00 |
| Mar 31, 2023 | 2.56 Mn |
| Dec 31, 2014 | -29,582.00 |
| Sep 30, 2014 | 23,281.00 |
| Jun 30, 2014 | 63,454.00 |
| Mar 31, 2014 | 14,934.00 |
| Dec 31, 2013 | 12,360.00 |
| Sep 30, 2013 | -33,383.00 |
| Jun 30, 2013 | -74,451.00 |
| Mar 31, 2013 | -59,577.00 |
| Dec 31, 2012 | -5,350.00 |
| Sep 30, 2012 | -1,229.00 |
| Jun 30, 2012 | -2,808.00 |
| Mar 31, 2012 | 2,069.00 |
| Dec 31, 2011 | 21,931.00 |
| Sep 30, 2011 | -329.00 |